Hurricane Helene damaged a Baxter plant in Marion, N.C., that makes 60% of the nation’s IV fluid products, in September, and hospitals are struggling amid the shortages.
Baxter International started to import IV fluids last week from two of its international manufacturing facilities to address supply shortages in the U.S.
Medline has signed a multi-year prime vendor distribution agreement with Visalia, Calif.-based Kaweah Health, California’s largest community healthcare organization which operates over 600 beds.
The CDC issued a health advisory Oct. 12 with guidelines on how systems and leaders can manage the supply disruptions of peritoneal dialysis and intravenous solutions.
Hospitals and health systems nationwide are implementing conservation strategies and exploring alternatives to address the national shortage of IV fluids.
Daytona Beach, Fla.-based B. Braun Medical plant, which produces nearly one-quarter of the IV fluids in the U.S., has emerged unscathed following Hurricane Milton, The New York Times reported Oct. 10.
The FDA may move to allow the temporary importation of intravenous fluids and related products from overseas manufacturing sites to address critical shortages exacerbated by Hurricane Helene, the agency told Becker’s Oct. 9.
Baxter on Oct. 8 said it has resumed shipments of IV products to hospitals and dialysis patients after a temporary week-long hold and is inspecting finished goods to support current allocations. Baxter also said several of the manufacturer’s global pla…
The American Hospital Association called on President Biden to declare the current intravenous IV solution shortage a national emergency in an Oct. 7 news release, citing significant challenges for healthcare providers across the U.S.